SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY

SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY

Bibliographic Details
Main Authors: M.M.O. Barros, A. Röth, W. Barcellini, T.H.A. Tvedt, Y. Miyakawa, D.J. Kuter, W. Hobbs, J. Su, X. Jiang, J.M. Arias, I.C. Weitz
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920303813
id doaj-af831b543f3b491996822a3149445f81
record_format Article
spelling doaj-af831b543f3b491996822a3149445f812020-11-25T04:00:49ZengElsevierHematology, Transfusion and Cell Therapy2531-13792020-11-01425758SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDYM.M.O. Barros0A. Röth1W. Barcellini2T.H.A. Tvedt3Y. Miyakawa4D.J. Kuter5W. Hobbs6J. Su7X. Jiang8J.M. Arias9I.C. Weitz10Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, BrazilDepartment of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyFondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milan, ItalySection for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, NorwayThrombosis and Hemostasis Center, Saitama Medical University Hospital, Saitama, JapanDivision of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, United StatesSanofi, Waltham, United StatesSanofi, Cambridge, United StatesJane Anne Nohl Division of Hematology, Department of Medicine, University of Southern California–Keck School of Medicine, Los Angeles, United StatesSanofi, Cambridge, United StatesJane Anne Nohl Division of Hematology, Department of Medicine, University of Southern California–Keck School of Medicine, Los Angeles, United Stateshttp://www.sciencedirect.com/science/article/pii/S2531137920303813
collection DOAJ
language English
format Article
sources DOAJ
author M.M.O. Barros
A. Röth
W. Barcellini
T.H.A. Tvedt
Y. Miyakawa
D.J. Kuter
W. Hobbs
J. Su
X. Jiang
J.M. Arias
I.C. Weitz
spellingShingle M.M.O. Barros
A. Röth
W. Barcellini
T.H.A. Tvedt
Y. Miyakawa
D.J. Kuter
W. Hobbs
J. Su
X. Jiang
J.M. Arias
I.C. Weitz
SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY
Hematology, Transfusion and Cell Therapy
author_facet M.M.O. Barros
A. Röth
W. Barcellini
T.H.A. Tvedt
Y. Miyakawa
D.J. Kuter
W. Hobbs
J. Su
X. Jiang
J.M. Arias
I.C. Weitz
author_sort M.M.O. Barros
title SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY
title_short SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY
title_full SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY
title_fullStr SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY
title_full_unstemmed SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY
title_sort sutimlimab, a complement c1s inhibitor, improves quality of life in patients with cold agglutinin disease: patient-reported outcomes results of the phase 3 cardinal study
publisher Elsevier
series Hematology, Transfusion and Cell Therapy
issn 2531-1379
publishDate 2020-11-01
url http://www.sciencedirect.com/science/article/pii/S2531137920303813
work_keys_str_mv AT mmobarros sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
AT aroth sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
AT wbarcellini sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
AT thatvedt sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
AT ymiyakawa sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
AT djkuter sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
AT whobbs sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
AT jsu sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
AT xjiang sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
AT jmarias sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
AT icweitz sutimlimabacomplementc1sinhibitorimprovesqualityoflifeinpatientswithcoldagglutinindiseasepatientreportedoutcomesresultsofthephase3cardinalstudy
_version_ 1724448958291378176

Similar Items